Evidence map›Paper›PMID 36205262›Full record

ArticleJournal of the American Heart Association2022

Association Among Polyphenol Intake, Uric Acid, and Hyperuricemia: A Cross-Sectional Analysis in a Population at High Cardiovascular Risk.

María Rubín-García, Facundo Vitelli-Storelli, Laura Álvarez-Álvarez, Miguel Ángel Martínez-González, Jordi Salas-Salvadó, Dolores Corella, Álvaro Hernáez, J Alfredo Martínez, Ángel M Alonso-Gómez, Julia Wärnberg and 42 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

52 authors at 15 institutions in 3 countries.

María Rubín-GarcíaGroup of Investigation in Interactions Gene-Environment and Health (GIIGAS) Institute of Biomedicine (IBIOMED), University of León Spain.ORCID 0000-0003-0916-4215
Facundo Vitelli-StorelliGroup of Investigation in Interactions Gene-Environment and Health (GIIGAS) Institute of Biomedicine (IBIOMED), University of León Spain.ORCID 0000-0002-3118-3570
Laura Álvarez-ÁlvarezGroup of Investigation in Interactions Gene-Environment and Health (GIIGAS) Institute of Biomedicine (IBIOMED), University of León Spain.ORCID 0000-0002-4915-8314
Miguel Ángel Martínez-GonzálezDepartment of Preventive Medicine and Public Health Navarra Institute for Health Research (IdiSNA), University of Navarra Pamplona Spain.ORCID 0000-0002-3917-9808
Jordi Salas-SalvadóCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.ORCID 0000-0003-2700-7459
Dolores CorellaCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.ORCID 0000-0001-8593-1477
Álvaro HernáezCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
J Alfredo MartínezCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Ángel M Alonso-GómezCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.ORCID 0000-0003-2945-7509
Julia WärnbergCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Jesús VioqueCIBER de Epidemiología y Salud Pública (CIBERESP) Instituto de Salud Carlos III Madrid Spain.
Dora RomagueraCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
José López-MirandaCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Ramon EstruchCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.ORCID 0000-0003-1260-4445
Francisco J TinahonesCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Luís I Serra-MajemCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Naomi Cano-IbañezInstituto de Investigación Biosanitaria ibs.GRANADA Complejo Hospitales Universitarios de Granada/Department of Preventive Medicine and Public Health, University of Granada Spain.
Josep A TurCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Alba Marcos-DelgadoGroup of Investigation in Interactions Gene-Environment and Health (GIIGAS) Institute of Biomedicine (IBIOMED), University of León Spain.ORCID 0000-0002-7852-1282
Anna Tresserra-RimbauCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Xavier PintóCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.ORCID 0000-0002-2216-2444
Miguel Delgado-RodríguezDepartment of Nutrition, Food Sciences, and Physiology University of Navarra Pamplona Spain.
Pilar Matía-MartínDepartment of Endocrinology and Nutrition Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC) Madrid Spain.
Josep VidalCIBER Diabetes y Enfermedades Metabólicas (CIBERDEM) Instituto de Salud Carlos III (ISCIII) Madrid Spain.
Clotilde VázquezCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Lidia DaimielNutritional Control of the Epigenome Group, Precision Nutrition, and Obesity Program, IMDEA Food CEI UAM+CSIC Madrid Spain.ORCID 0000-0001-9898-6629
Emili RosCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.ORCID 0000-0002-2573-1294
Zenaida Vázquez-RuizDepartment of Preventive Medicine and Public Health Navarra Institute for Health Research (IdiSNA), University of Navarra Pamplona Spain.ORCID 0000-0002-6828-9627
Nancy BabioCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Rocío BarragánCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Olga Castañer-NiñoPrecision Nutrition Programme IMDEA Food, CEI UAM+CSIC Madrid Spain.ORCID 0000-0003-3169-997X
Cristina RazquinDepartment of Preventive Medicine and Public Health Navarra Institute for Health Research (IdiSNA), University of Navarra Pamplona Spain.
Lucas Tojal-SierraCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Enrique Gómez-GraciaInstituto de Investigación Biomédica de Málaga-IBIMA Málaga Spain.
Sandra González-PalaciosCIBER de Epidemiología y Salud Pública (CIBERESP) Instituto de Salud Carlos III Madrid Spain.
Marga MoreyCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Antonio García-RiosCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Sara Castro-BarqueroCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.ORCID 0000-0002-6876-5443
María Rosa Bernal-LópezCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.ORCID 0000-0002-0238-0890
José Manuel Santos-LozanoCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.ORCID 0000-0001-7097-5653
Miguel Ruiz-CanelaDepartment of Preventive Medicine and Public Health Navarra Institute for Health Research (IdiSNA), University of Navarra Pamplona Spain.ORCID 0000-0002-7684-2787
Antoni Castro-SalomóUniversity Hospital of Sant Joan de Reus, Servei de Medicina Interna, Unitat de Nutrició Reus Spain.
Eva Cristina Pascual-CastellóDepartment of Preventive Medicine University of Valencia Spain.
Verónica MoldonPrecision Nutrition Programme IMDEA Food, CEI UAM+CSIC Madrid Spain.
Vanessa Bullón-VelaDepartment of Preventive Medicine and Public Health Navarra Institute for Health Research (IdiSNA), University of Navarra Pamplona Spain.ORCID 0000-0003-3639-821X
Carolina Sorto-SanchezCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.ORCID 0000-0001-7114-5299
Juan Carlos Cenoz-OsinagaDepartment of Preventive Medicine and Public Health Navarra Institute for Health Research (IdiSNA), University of Navarra Pamplona Spain.
Liliana GutiérrezUniversity Hospital of Sant Joan de Reus, Servei de Medicina Interna, Unitat de Nutrició Reus Spain.ORCID 0000-0001-7809-3903
Maira MengualPrecision Nutrition Programme IMDEA Food, CEI UAM+CSIC Madrid Spain.ORCID 0000-0002-8848-266X
Rosa María Lamuela-RaventósCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Vicente Martín-SánchezGroup of Investigation in Interactions Gene-Environment and Health (GIIGAS) Institute of Biomedicine (IBIOMED), University of León Spain.ORCID 0000-0003-0552-2804
PREDIMED‐Plus Trial Investigators
Instituto de Salud Carlos III · ESMadrid Institute for Advanced Studies · ESUniversidad de León · ESUniversitat de València · ESUniversity of the Basque Country · ESInstitut de Recerca Biomèdica Catalunya Sud · ESUniversidad de Las Palmas de Gran Canaria · ESUniversidad de Navarra · ESUniversitat de Miguel Hernández d'Elx · ESHarvard University · USInstituto de Investigación Biomédica de Málaga · ESInstituto de Investigación Sanitaria del Hospital Clínico San Carlos · ESNorwegian Institute of Public Health · NOUniversidad de Granada · ESUniversidad de Jaén · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Dietary polyphenol intake has been associated with a decreased risk of hyperuricemia, but most of this knowledge comes from preclinical studies. The aim of the present study was to assess the association of the intake of different classes of polyphenols with serum uric acid and hyperuricemia. Methods and Results This cross-sectional analysis involved baseline data of 6332 participants. Food polyphenol content was estimated by a validated semiquantitative food frequency questionnaire and from the Phenol-Explorer database. Multivariable-adjusted linear regression models with serum uric acid (milligrams per deciliter) as the outcome and polyphenol intake (quintiles) as the main independent variable were fitted. Cox regression models with constant follow-up time (t=1) were performed to estimate the prevalence ratios (PRs) of hyperuricemia (≥7 mg/dL in men and ≥6 mg/dL in women). An inverse association between the intake of the phenolic acid class (β coefficient, -0.17 mg/dL for quintile 5 versus quintile 1 [95% CI, -0.27 to -0.06]) and hydroxycinnamic acids (β coefficient, -0.19 [95% CI, -0.3 to -0.09]), alkylmethoxyphenols (β coefficient, -0.2 [95% CI, -0.31 to -0.1]), and methoxyphenols (β coefficient, -0.24 [95% CI, -0.34 to -0.13]) subclasses with serum uric acid levels and hyperuricemia (PR, 0.82 [95% CI, 0.71-0.95]; PR, 0.82 [95% CI, 0.71-0.95]; PR, 0.80 [95% CI, 0.70-0.92]; and PR, 0.79 [95% CI, 0.69-0.91]; respectively) was found. The intake of hydroxybenzoic acids was directly and significantly associated with mean serum uric acid levels (β coefficient, 0.14 for quintile 5 versus quintile 1 [95% CI, 0.02-0.26]) but not with hyperuricemia. Conclusions In individuals with metabolic syndrome, a higher intake of some polyphenol subclasses (hydroxycinnamic acids, alkylmethoxyphenol, and methoxyphenol) was inversely associated with serum uric acid levels and hyperuricemia. Nevertheless, our findings warrant further research.

Indexed as

Cardiovascular DiseasesHyperuricemiaCoumaric AcidsCross-Sectional StudiesFemaleHeart Disease Risk FactorsHumansHydroxybenzoatesMalePolyphenolsRisk FactorsUric AcidCoumaric AcidsHydroxybenzoatesPolyphenolsUric Acidhyperuricemiapolyphenolsuric acid

Identifiers

PMID36205262
PMCPMC9673670
OpenAlexW4303415468

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.